Drugs and the Pharmaceutical Sciences V.150
Author :
Publisher :
Page : 471 pages
File Size : 41,36 MB
Release : 2005
Category : Laboratories
ISBN :
Author :
Publisher :
Page : 471 pages
File Size : 41,36 MB
Release : 2005
Category : Laboratories
ISBN :
Author :
Publisher :
Page : pages
File Size : 36,76 MB
Release :
Category :
ISBN :
Author : [Anonymus AC00425757]
Publisher :
Page : pages
File Size : 45,52 MB
Release : 1975
Category :
ISBN :
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 103 pages
File Size : 24,47 MB
Release : 2020-01-27
Category : Medical
ISBN : 0309498511
To explore the role of the National Institutes of Health (NIH) in innovative drug development and its impact on patient access, the Board on Health Care Services and the Board on Health Sciences Policy of the National Academies jointly hosted a public workshop on July 24â€"25, 2019, in Washington, DC. Workshop speakers and participants discussed the ways in which federal investments in biomedical research are translated into innovative therapies and considered approaches to ensure that the public has affordable access to the resulting new drugs. This publication summarizes the presentations and discussions from the workshop.
Author : John Jensen
Publisher :
Page : 226 pages
File Size : 16,88 MB
Release : 2019-06-10
Category : Medical
ISBN : 9781632428288
Any substance which causes a temporary physiological or psychological change in the body on being consumed, inhaled, smoked or absorbed is called a drug. Pharmaceutical drugs are the chemical substances which are used to prevent, diagnose, cure or treat diseases or to promote well-being. They can be used for limited period or on regular basis according to the diseases. They are produced from medicinal plants or by organic synthesis. The domain of pharmaceutical science is concerned with the design, delivery, disposition and action of such drugs. The topics included in this book on drugs and pharmaceutical sciences are of utmost significance and bound to provide incredible insights to readers. It strives to provide a fair idea about this discipline and to help develop a better understanding of the latest advances within this field. For all those who are interested in drugs and pharmaceutical sciences, this book can prove to be an essential guide.
Author : Institute of Medicine
Publisher : National Academies Press
Page : 241 pages
File Size : 19,1 MB
Release : 1990-02-01
Category : Medical
ISBN : 0309042860
The very rapid pace of advances in biomedical research promises us a wide range of new drugs, medical devices, and clinical procedures. The extent to which these discoveries will benefit the public, however, depends in large part on the methods we choose for developing and testing them. Modern Methods of Clinical Investigation focuses on strategies for clinical evaluation and their role in uncovering the actual benefits and risks of medical innovation. Essays explore differences in our current systems for evaluating drugs, medical devices, and clinical procedures; health insurance databases as a tool for assessing treatment outcomes; the role of the medical profession, the Food and Drug Administration, and industry in stimulating the use of evaluative methods; and more. This book will be of special interest to policymakers, regulators, executives in the medical industry, clinical researchers, and physicians.
Author : National Library of Medicine (U.S.)
Publisher :
Page : 1628 pages
File Size : 18,44 MB
Release : 1993
Category : Medicine
ISBN :
First multi-year cumulation covers six years: 1965-70.
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 235 pages
File Size : 38,55 MB
Release : 2018-03-01
Category : Medical
ISBN : 0309468086
Thanks to remarkable advances in modern health care attributable to science, engineering, and medicine, it is now possible to cure or manage illnesses that were long deemed untreatable. At the same time, however, the United States is facing the vexing challenge of a seemingly uncontrolled rise in the cost of health care. Total medical expenditures are rapidly approaching 20 percent of the gross domestic product and are crowding out other priorities of national importance. The use of increasingly expensive prescription drugs is a significant part of this problem, making the cost of biopharmaceuticals a serious national concern with broad political implications. Especially with the highly visible and very large price increases for prescription drugs that have occurred in recent years, finding a way to make prescription medicinesâ€"and health care at largeâ€"more affordable for everyone has become a socioeconomic imperative. Affordability is a complex function of factors, including not just the prices of the drugs themselves, but also the details of an individual's insurance coverage and the number of medical conditions that an individual or family confronts. Therefore, any solution to the affordability issue will require considering all of these factors together. The current high and increasing costs of prescription drugsâ€"coupled with the broader trends in overall health care costsâ€"is unsustainable to society as a whole. Making Medicines Affordable examines patient access to affordable and effective therapies, with emphasis on drug pricing, inflation in the cost of drugs, and insurance design. This report explores structural and policy factors influencing drug pricing, drug access programs, the emerging role of comparative effectiveness assessments in payment policies, changing finances of medical practice with regard to drug costs and reimbursement, and measures to prevent drug shortages and foster continued innovation in drug development. It makes recommendations for policy actions that could address drug price trends, improve patient access to affordable and effective treatments, and encourage innovations that address significant needs in health care.
Author : National Academies of Sciences, Engineering, and Medicine
Publisher : National Academies Press
Page : 483 pages
File Size : 33,87 MB
Release : 2017-09-28
Category : Medical
ISBN : 0309459575
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Author : National Library of Medicine (U.S.)
Publisher :
Page : 1068 pages
File Size : 39,52 MB
Release : 1991
Category : Medicine
ISBN :